Literature DB >> 27460223

Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia.

Toru Arai1, Tomoko Kagawa1,2, Yumiko Sasaki1,2, Reiko Sugawara2, Chikatoshi Sugimoto3, Kazunobu Tachibana1,2, Masanori Kitaichi4,5, Masanori Akira1,6, Seiji Hayashi2, Yoshikazu Inoue7.   

Abstract

BACKGROUND AND
OBJECTIVE: Acute exacerbations (AEs) of idiopathic pulmonary fibrosis (IPF) and other idiopathic interstitial pneumonia (IIP) have a poor prognosis. This study aims to clarify the incidence and prognosis of AE in IPF and the other IIP.
METHODS: A total of 229 patients were enrolled, of whom 92 had IPF and 137 had 'IIP other than IPF' based on the American Thoracic Society/European Respiratory Society/Japanese Respiratory Society/Latin American Thoracic Association (ATS/ERS/JRS/ALAT) 2011 IPF Guidelines. IIP other than IPF included 11 patients with a surgical lung biopsy (SLB) and the remainder without such a biopsy. IIP other than IPF was further classified into IIP with a 'possible usual interstitial pneumonia (UIP)' pattern on HRCT (n = 75) and IIP with 'inconsistent with UIP' pattern (n = 62) based on published guidelines. Predictors of AE and the prognosis after AE were examined in these groups.
RESULTS: The 1-year incidence of AE in IPF, IIP with possible UIP HRCT patterns and IIP with inconsistent with UIP HRCT patterns was 16.5%, 8.9% and 4.0%, respectively. AE occurred significantly more frequently in IPF than in IIP with possible UIP and inconsistent with UIP HRCT patterns after adjustment for BMI, modified Medical Research Council score and %forced vital capacity. Prognosis of AE-IIP with possible UIP HRCT pattern was significantly worse than that of AE-IPF.
CONCLUSION: Although AE occurred significantly less frequently in IIP with possible UIP and inconsistent with UIP HRCT patterns than in IPF, the prognosis of AE-IIP with possible UIP HRCT patterns might be worse than that of AE-IPF.
© 2016 Asian Pacific Society of Respirology.

Entities:  

Keywords:  acute exacerbation; high-resolution computed tomography; idiopathic interstitial pneumonia; idiopathic pulmonary fibrosis; usual interstitial pneumonia

Mesh:

Year:  2016        PMID: 27460223     DOI: 10.1111/resp.12862

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  14 in total

1.  Clinical characteristics of idiopathic interstitial pneumonias with anti-Ro52/tripartite motif-containing 21 antibodies.

Authors:  Masahiro Tahara; Noriho Sakamoto; Minoru Satoh; Hiroshi Ishimoto; Hirokazu Yura; Kei Yamasaki; Takashi Kido; Yoshihisa Fujino; Tomoko Hasegawa; Shin Tanaka; Kazuhiro Yatera; Hiroshi Mukae
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

2.  Clinical significance of Charlson comorbidity index as a prognostic parameter for patients with acute or subacute idiopathic interstitial pneumonias and acute exacerbation of collagen vascular diseases-related interstitial pneumonia.

Authors:  Kota Murohashi; Yu Hara; Yusuke Saigusa; Nobuaki Kobayashi; Takashi Sato; Masaki Yamamoto; Makoto Kudo; Takeshi Kaneko
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

Review 3.  Acute exacerbation of interstitial lung disease associated with rheumatic disease.

Authors:  Fabrizio Luppi; Marco Sebastiani; Carlo Salvarani; Elisabeth Bendstrup; Andreina Manfredi
Journal:  Nat Rev Rheumatol       Date:  2021-12-07       Impact factor: 20.543

Review 4.  Characteristics and evaluation of acute exacerbations in chronic interstitial lung diseases.

Authors:  Corey D Kershaw; Kiran Batra; Jose R Torrealba; Lance S Terada
Journal:  Respir Med       Date:  2021-04-26       Impact factor: 4.582

5.  Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trial.

Authors:  Toru Arai; Hiroshi Kida; Yoshitaka Ogata; Satoshi Marumo; Hiroto Matsuoka; Iwao Gohma; Suguru Yamamoto; Masahide Mori; Chikatoshi Sugimoto; Kazunobu Tachibana; Masanori Akira; Yoshikazu Inoue
Journal:  BMJ Open Respir Res       Date:  2020-05

Review 6.  The Role of Infection in Interstitial Lung Diseases: A Review.

Authors:  Natalya Azadeh; Andrew H Limper; Eva M Carmona; Jay H Ryu
Journal:  Chest       Date:  2017-04-08       Impact factor: 9.410

7.  Seroradiologic prognostic evaluation of acute exacerbation in patients with idiopathic interstitial pneumonia: a retrospective observational study.

Authors:  Toru Arai; Masanori Akira; Chikatoshi Sugimoto; Kazunobu Tachibana; Yasushi Inoue; Sayoko Shintani; Tomohisa Okuma; Takahiko Kasai; Seiji Hayashi; Yoshikazu Inoue
Journal:  J Thorac Dis       Date:  2020-08       Impact factor: 2.895

8.  Feasibility and Outcomes of a Standardized Management Protocol for Acute Exacerbation of Interstitial Lung Disease.

Authors:  Colin J Adams; Karan Chohan; Dmitry Rozenberg; John Kavanagh; Gerhard Greyling; Shane Shapera; Jolene H Fisher
Journal:  Lung       Date:  2021-08-04       Impact factor: 2.584

9.  Acute exacerbation of idiopathic pulmonary fibrosis: usual interstitial pneumonitis vs. possible usual interstitial pneumonitis pattern.

Authors:  Meng-Shu Cao; Jian Sheng; Tian-Zhen Wang; Xiao-Hua Qiu; Dong-Mei Wang; Yang Wang; Yong-Long Xiao; Hou-Rong Cai
Journal:  Chin Med J (Engl)       Date:  2019-09-20       Impact factor: 2.628

10.  Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases.

Authors:  Johanna Salonen; Minna Purokivi; Risto Bloigu; Riitta Kaarteenaho
Journal:  BMJ Open Respir Res       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.